The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 8, 2009, Pages 768-772

  Hwang, You Cheol ^a   Jeong, In Kyung ^a   Ahn, Kyu Jeung ^a   Chung, Ho Yeon ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

cell function; Glucose tolerance; Insulin sensitivity; Osteocalcin

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADULT; AGING; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DECARBOXYLATION; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OSTEOCALCIN; PANCREAS; PREDIABETIC STATE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 73349104406     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1045     Document Type: Article

References (19)

1. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130(3): 456-469.
2. Ferron M,Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008; 105(13): 5266-5270.
3. Fernandez-Real JM, Izquierdo M, Ortega F, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009; 94(1): 237-245.
4. Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008; 396(1-2): 66-69.
5. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94(1): 45-49.
6. Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J BoneMiner Res 2008; 24(5): 785-791.
7. Pittas AG, Harris SS, Eliades M, StarkP, Dawson-HughesB. Association between serum osteocalcin andmarkers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94(3): 827-832.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(1): S62-S67.
9. Vestri HS, Lara-Castro C, Moellering DR, Gunberg CM, Garvey WT. Osteocalcin is not just for bones: effects on adipocytes and role in human metabolism. Diabetes 2008; 57: A29.
10. Berkner KL. The vitamin K-dependent carboxylase. Annu Rev Nutr 2005; 25: 127-149.
11. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91(4): 1769-1774.
12. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994; 9(10): 1591-1595.
13. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 1991; 6(11): 1211-1216.
14. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Linseisen J. Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab 2007; 51(6): 563-570.
15. Gundberg CM, Looker AC, Nieman SD, Calvo MS. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 2002; 31(6): 703-708.
16. Looker AC, Bauer DC, Chesnut CH III, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 2000; 11(6): 467-480.
17. Seibel MJ. Biochemical markers of bone remodeling. Endocrinol Metab Clin North Am 2003; 32(1): 83-113.
18. Demay MB, Roth DA, Kronenberg HM. Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription. J Biol Chem 1989; 264(4): 2279-2282.
19. Kesterson RA, Stanley L, DeMayo F, Finegold M, Pike JW. The human osteocalcin promoter directs bone-specific vitamin Dregulatable gene expression in transgenic mice. Mol Endocrinol 1993; 7(3): 462-467.